Uterine Cervical Neoplasms

"Uterine Cervical Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the UTERINE CERVIX.

Descriptor ID	D002583
MeSH Number(s)	C04.588.945.418.948.850 C13.351.500.852.593.131 C13.351.500.852.762.850 C13.351.937.418.875.850
Concept/Terms	Uterine Cervical Neoplasms Uterine Cervical Neoplasms Cervical Neoplasm, Uterine Cervical Neoplasms, Uterine Neoplasm, Uterine Cervical Neoplasms, Uterine Cervical Uterine Cervical Neoplasm Neoplasms, Cervical Cervical Neoplasms Cervical Neoplasm Neoplasm, Cervical Neoplasms, Cervix Cervix Neoplasms Cervix Neoplasm Neoplasm, Cervix Cancer of the Uterine Cervix Cancer of the Uterine Cervix Cancer of the Cervix Cervical Cancer Uterine Cervical Cancer Cancer, Uterine Cervical Cancers, Uterine Cervical Cervical Cancer, Uterine Cervical Cancers, Uterine Uterine Cervical Cancers Cancer of Cervix Cervix Cancer Cancer, Cervix Cancers, Cervix

Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Female [C04.588.945.418]
Uterine Neoplasms [C04.588.945.418.948]
Uterine Cervical Neoplasms [C04.588.945.418.948.850]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Genital Diseases, Female [C13.351.500]
Uterine Diseases [C13.351.500.852]
Uterine Cervical Diseases [C13.351.500.852.593]
Uterine Cervical Neoplasms [C13.351.500.852.593.131]
Uterine Neoplasms [C13.351.500.852.762]
Uterine Cervical Neoplasms [C13.351.500.852.762.850]
Urogenital Neoplasms [C13.351.937]
Genital Neoplasms, Female [C13.351.937.418]
Uterine Neoplasms [C13.351.937.418.875]
Uterine Cervical Neoplasms [C13.351.937.418.875.850]

Below are MeSH descriptors whose meaning is related to "Uterine Cervical Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Uterine Cervical Neoplasms" by people in this website by year, and whether "Uterine Cervical Neoplasms" was a major or minor topic of these publications.

Bar chart showing 149 publications over 29 distinct years, with a maximum of 14 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	2	1	3
1993	2	0	2
1994	2	0	2
1995	4	0	4
1996	1	0	1
1997	1	0	1
1998	3	0	3
1999	3	0	3
2000	4	0	4
2001	5	2	7
2002	1	0	1
2003	6	1	7
2004	4	0	4
2005	7	2	9
2006	4	2	6
2007	2	0	2
2008	2	0	2
2009	12	2	14
2010	4	0	4
2011	6	1	7
2012	5	1	6
2013	2	2	4
2014	7	1	8
2015	9	2	11
2016	8	0	8
2017	11	2	13
2018	6	0	6
2019	2	2	4
2020	3	0	3

Below are the most recent publications written about "Uterine Cervical Neoplasms" by people in Profiles.

Ford ME, Cannady K, Nahhas GJ, Knight KD, Chavis C, Crawford B, Malek AM, Martino E, Frazier S, Gathers A, Lawton C, Cartmell KB, Luque JS. Assessing an intervention to increase knowledge related to cervical cancer and the HPV vaccine. Adv Cancer Res. 2020; 146:115-137.

View in: PubMed
Adams SA, Haynes VE, Brandt HM, Choi SK, Young V, Eberth JM, Hébert JR, Friedman DB. Cervical cancer screening behaviors and proximity to federally qualified health centers in South Carolina. Cancer Epidemiol. 2020 04; 65:101681.

View in: PubMed
Karan D, Dubey S, Pirisi L, Nagel A, Pina I, Choo YM, Hamann MT. The Marine Natural Product Manzamine A Inhibits Cervical Cancer by Targeting the SIX1 Protein. J Nat Prod. 2020 02 28; 83(2):286-295.

View in: PubMed
Hung P, Deng S, Zahnd WE, Adams SA, Olatosi B, Crouch EL, Eberth JM. Geographic disparities in residential proximity to colorectal and cervical cancer care providers. Cancer. 2020 03 01; 126(5):1068-1076.

View in: PubMed
Brandt HM, Vanderpool RC, Curry SJ, Farris P, Daniel-Ulloa J, Seegmiller L, Stradtman LR, Vu T, Taylor V, Zubizarreta M. A multi-site case study of community-clinical linkages for promoting HPV vaccination. Hum Vaccin Immunother. 2019; 15(7-8):1599-1606.

View in: PubMed
Sundstrom B, Smith E, Delay C, Luque JS, Davila C, Feder B, Paddock V, Poudrier J, Pierce JY, Brandt HM. A reproductive justice approach to understanding women's experiences with HPV and cervical cancer prevention. Soc Sci Med. 2019 07; 232:289-297.

View in: PubMed
McLaughlin C, Kim NK, Bandyopadhyay D, Deng X, Kaplan B, Matin K, Fields EC. Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis. Radiother Oncol. 2019 04; 133:50-53.

View in: PubMed
Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019 Jan - Feb; 18(1):29-37.

View in: PubMed
Alber JM, Brewer NT, Melvin C, Yackle A, Smith JS, Ko LK, Crawford A, Glanz K. Reducing overuse of cervical cancer screening: A systematic review. Prev Med. 2018 11; 116:51-59.

View in: PubMed
Luque JS, Tarasenko YN, Chen C. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014. J Prim Prev. 2018 08; 39(4):329-344.

View in: PubMed

People

Explore

Similar Concepts

Top Journals